RHUMBLINE ADVISERS - REATA PHARMACEUTICALS INC ownership

REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 154 filers reported holding REATA PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.63 and the average weighting 0.1%.

Quarter-by-quarter ownership
RHUMBLINE ADVISERS ownership history of REATA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$4,897,444
+133200.1%
48,033
+18.9%
0.01%0.0%
Q1 2023$3,674
+148.2%
40,408
+3.7%
0.01%
+150.0%
Q4 2022$1,480
-99.8%
38,952
+2.2%
0.00%
+100.0%
Q3 2022$958,000
-9.5%
38,112
+9.4%
0.00%
-50.0%
Q2 2022$1,059,000
+7.8%
34,845
+16.2%
0.00%
+100.0%
Q1 2022$982,000
+24.0%
29,981
-0.2%
0.00%0.0%
Q4 2021$792,000
-74.1%
30,046
-1.3%
0.00%
-75.0%
Q3 2021$3,062,000
-28.3%
30,437
+0.9%
0.00%
-33.3%
Q2 2021$4,270,000
+68.7%
30,169
+18.8%
0.01%
+100.0%
Q1 2021$2,531,000
-21.1%
25,390
-2.2%
0.00%
-25.0%
Q4 2020$3,209,000
+26.9%
25,959
-0.0%
0.00%0.0%
Q3 2020$2,529,000
-41.7%
25,960
-6.7%
0.00%
-42.9%
Q2 2020$4,340,000
-21.4%
27,817
-27.3%
0.01%
-41.7%
Q1 2020$5,520,000
-23.1%
38,246
+8.9%
0.01%0.0%
Q4 2019$7,178,000
+186.2%
35,112
+12.4%
0.01%
+140.0%
Q3 2019$2,508,000
-9.9%
31,232
+5.9%
0.01%0.0%
Q2 2019$2,784,000
+30.3%
29,503
+18.0%
0.01%
+25.0%
Q1 2019$2,137,000
+52.4%
25,002
+0.0%
0.00%
+33.3%
Q4 2018$1,402,000
+2.0%
24,995
+48.7%
0.00%0.0%
Q3 2018$1,374,000
+155.4%
16,806
+9.3%
0.00%
+200.0%
Q2 2018$538,000
+155.0%
15,375
+49.8%
0.00%
Q1 2018$211,000
-26.0%
10,265
+2.0%
0.00%
-100.0%
Q4 2017$285,000
-7.8%
10,065
+1.4%
0.00%0.0%
Q3 2017$309,000
+2.0%
9,927
+3.7%
0.00%0.0%
Q2 2017$303,0009,5770.00%
Other shareholders
REATA PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Conrad N. Hilton Foundation 63,481$7,847,000100.00%
CPMG Inc 2,896,901$358,115,00055.16%
PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE 140,000$17,307,00026.62%
Corriente Advisors, LLC 525,000$64,901,00015.45%
DUMAC, INC. 76,050$9,401,0007.33%
MADDEN SECURITIES Corp 35,152$4,345,0002.80%
Biondo Investment Advisors, LLC 113,692$14,055,0002.69%
Duquesne Family Office 749,897$92,702,0002.50%
LBJ Family Wealth Advisors, Ltd. 30,368$3,754,0002.44%
Integral Health Asset Management, LLC 50,000$6,181,0001.84%
View complete list of REATA PHARMACEUTICALS INC shareholders